Senaratne, W.V.Pinidiyapathirage, M.J.Perera, G.A.M.H.E.Wickremasinghe, A.R.2016-01-142016-01-142006The Ceylon Medical Journal, 51(1)pp.9-14https://dl.nsf.gov.lk/handle/1/21050Medical SciencesAnti-tuberculosis drug induced hepatitis-AIHTuberculosisDrug therapyDisease managementRisk factorsLiver functionWHO treatment recommendationsSide effectsHepatotoxicityRifampicinAnti-tuberculosis drug induced hepatitis - a Sri Lankan experienceArticle